NYT article on orforglipron phase 3 trial and Eli Lilly's plan to seek FDA approval in 2025

keangkong

GLP-1 Specialist
Member Since
Sep 2, 2024
Posts
1,386
Likes Received
3,736
From
Ryongsong Residence, Pyongyang, North Korea
"Eli Lilly will not be announcing a price for orforglipron before it is approved for marketing."
 
Top Bottom